Literature DB >> 19417858

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of risk.

Raj S Padwal1, Brenda R Hemmelgarn, Nadia A Khan, Steven Grover, Donald W McKay, Thomas Wilson, Brian Penner, Ellen Burgess, Finlay A McAlister, Peter Bolli, Machael D Hill, Jeff Mahon, Martin G Myers, Carl Abbott, Ernesto L Schiffrin, George Honos, Karen Mann, Guy Tremblay, Alain Milot, Lyne Cloutier, Arun Chockalingam, Simon W Rabkin, Martin Dawes, Rhian M Touyz, Chaim Bell, Kevin D Burns, Marcel Ruzicka, Norman R C Campbell, Michel Vallée, Ramesh Prasad, Marcel Lebel, Sheldon W Tobe.   

Abstract

OBJECTIVE: To provide updated, evidence-based recommendations for the diagnosis and assessment of adults with hypertension. OPTIONS AND OUTCOMES: The diagnosis of hypertension is dependent on appropriate blood pressure measurement, the timely assessment of serially elevated readings, the degree of blood pressure elevation, the method of measurement (office, ambulatory, home) and associated comorbidities. The presence of cardiovascular risk factors and target organ damage should be ascertained to assess global cardiovascular risk and determine the urgency, intensity and type of treatment required. EVIDENCE: MEDLINE searches were conducted from November 2007 to October 2008 with the aid of a medical librarian. Reference lists were scanned, experts were contacted, and the personal files of authors and subgroup members were used to identify additional studies. Content and methodological experts assessed studies using prespecified, standardized evidence-based algorithms. Recommendations were based on evidence from peer-reviewed full-text articles only. RECOMMENDATIONS: Recommendations for blood pressure measurement, criteria for hypertension diagnosis and follow-up, assessment of global cardiovascular risk, diagnostic testing, diagnosis of renovascular and endocrine causes of hypertension, home and ambulatory monitoring, and the use of echocardiography in hypertensive individuals are outlined. Key messages include continued emphasis on the expedited, accurate diagnosis of hypertension, the importance of global risk assessment and the need for ongoing monitoring of hypertensive patients to identify incident type 2 diabetes. VALIDATION: All recommendations were graded according to strength of the evidence and voted on by the 57 members of the Canadian Hypertension Education Program Evidence-Based Recommendations Task Force. All recommendations were required to be supported by at least 70% of task force members. These guidelines will continue to be updated annually.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19417858      PMCID: PMC2707176          DOI: 10.1016/s0828-282x(09)70491-x

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  38 in total

Review 1.  A novel process for updating recommendations for managing hypertension: rationale and methods.

Authors:  K B Zarnke; N R Campbell; F A McAlister; M Levine
Journal:  Can J Cardiol       Date:  2000-09       Impact factor: 5.223

2.  Primary and subsequent coronary risk appraisal: new results from the Framingham study.

Authors:  R B D'Agostino; M W Russell; D M Huse; R C Ellison; H Silbershatz; P W Wilson; S C Hartz
Journal:  Am Heart J       Date:  2000-02       Impact factor: 4.749

3.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

Authors:  R B D'Agostino; S Grundy; L M Sullivan; P Wilson
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

4.  Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.

Authors:  Peter S Sever; Björn Dahlöf; Neil R Poulter; Hans Wedel; Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal:  Lancet       Date:  2003-04-05       Impact factor: 79.321

5.  The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

Authors:  R J Stevens; V Kothari; A I Adler; I M Stratton
Journal:  Clin Sci (Lond)       Date:  2001-12       Impact factor: 6.124

6.  Assessment of renal artery stenosis: comparison of captopril renography and gadolinium-enhanced breath-hold MR angiography.

Authors:  V Bongers; J Bakker; J J Beutler; F J Beek; J M De Klerk
Journal:  Clin Radiol       Date:  2000-05       Impact factor: 2.350

7.  UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.

Authors:  Viti Kothari; Richard J Stevens; Amanda I Adler; Irene M Stratton; Susan E Manley; H Andrew Neil; Rudy R Holman
Journal:  Stroke       Date:  2002-07       Impact factor: 7.914

8.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Authors:  R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

9.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

Review 10.  Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis.

Authors:  F G R Fowkes; G D Murray; I Butcher; C L Heald; R J Lee; L E Chambless; A R Folsom; A T Hirsch; M Dramaix; G deBacker; J-C Wautrecht; M Kornitzer; A B Newman; M Cushman; K Sutton-Tyrrell; F G R Fowkes; A J Lee; J F Price; R B d'Agostino; J M Murabito; P E Norman; K Jamrozik; J D Curb; K H Masaki; B L Rodríguez; J M Dekker; L M Bouter; R J Heine; G Nijpels; C D A Stehouwer; L Ferrucci; M M McDermott; H E Stoffers; J D Hooi; J A Knottnerus; M Ogren; B Hedblad; J C Witteman; M M B Breteler; M G M Hunink; A Hofman; M H Criqui; R D Langer; A Fronek; W R Hiatt; R Hamman; H E Resnick; J Guralnik; M M McDermott
Journal:  JAMA       Date:  2008-07-09       Impact factor: 56.272

View more
  26 in total

1.  2011 Canadian Hypertension Education Program recommendations: an annual update.

Authors:  Norm Campbell
Journal:  Can Fam Physician       Date:  2011-12       Impact factor: 3.275

Review 2.  Annual adult health checkup: update on the Preventive Care Checklist Form(©).

Authors:  Anthony Duerksen; Vinita Dubey; Karl Iglar
Journal:  Can Fam Physician       Date:  2012-01       Impact factor: 3.275

3.  2010 Canadian Hypertension Education Program recommendations: An annual update.

Authors:  Norm Campbell; Margaret Moy Lum Kwong
Journal:  Can Fam Physician       Date:  2010-07       Impact factor: 3.275

4.  Home blood pressure monitoring among Canadian adults with hypertension: results from the 2009 Survey on Living with Chronic Diseases in Canada.

Authors:  Christina M Bancej; Norm Campbell; Donald W McKay; Marianne Nichol; Robin L Walker; Janusz Kaczorowski
Journal:  Can J Cardiol       Date:  2010-05       Impact factor: 5.223

5.  Management of hypertension: Regional variations in a greatly improved landscape.

Authors:  Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2010-10       Impact factor: 5.223

6.  Underrepresentation of individuals 80 years of age and older in chronic disease clinical practice guidelines.

Authors:  Lizebeth Cox; Marita Kloseck; Richard Crilly; Carol McWilliam; Laura Diachun
Journal:  Can Fam Physician       Date:  2011-07       Impact factor: 3.275

7.  Taking blood pressure-lowering medications at night.

Authors:  Ricky Turgeon; G Michael Allan
Journal:  Can Fam Physician       Date:  2012-09       Impact factor: 3.275

Review 8.  The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk.

Authors:  Robert R Quinn; Brenda R Hemmelgarn; Raj S Padwal; Martin G Myers; Lyne Cloutier; Peter Bolli; Donald W McKay; Nadia A Khan; Michael D Hill; Jeff Mahon; Daniel G Hackam; Steven Grover; Thomas Wilson; Brian Penner; Ellen Burgess; Finlay A McAlister; Maxime Lamarre-Cliche; Donna McLean; Ernesto L Schiffrin; George Honos; Karen Mann; Guy Tremblay; Alain Milot; Arun Chockalingam; Simon W Rabkin; Martin Dawes; Rhian M Touyz; Kevin D Burns; Marcel Ruzicka; Norman R C Campbell; Michel Vallée; G V Ramesh Prasad; Marcel Lebel; Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2010-05       Impact factor: 5.223

9.  Intensive blood-pressure control in hypertensive chronic kidney disease.

Authors:  Lawrence J Appel; Jackson T Wright; Tom Greene; Lawrence Y Agodoa; Brad C Astor; George L Bakris; William H Cleveland; Jeanne Charleston; Gabriel Contreras; Marquetta L Faulkner; Francis B Gabbai; Jennifer J Gassman; Lee A Hebert; Kenneth A Jamerson; Joel D Kopple; John W Kusek; James P Lash; Janice P Lea; Julia B Lewis; Michael S Lipkowitz; Shaul G Massry; Edgar R Miller; Keith Norris; Robert A Phillips; Velvie A Pogue; Otelio S Randall; Stephen G Rostand; Miroslaw J Smogorzewski; Robert D Toto; Xuelei Wang
Journal:  N Engl J Med       Date:  2010-09-02       Impact factor: 91.245

10.  Pay-for-performance remuneration for pharmacist prescribers' management of hypertension: A substudy of the RxACTION trial.

Authors:  Sherilyn K D Houle; Theresa L Charrois; Finlay A McAlister; Michael R Kolber; Meagen M Rosenthal; Richard Lewanczuk; Norman R C Campbell; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2016-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.